We are live on
!
Find out more
FRA
Front Row Advisors Portfolio holdings
AUM
$296M
1-Year Est. Return
34.73%
This Fund
S&P 500
This Quarter
Est. Return
+17.22%
1 Year Est. Return
+34.73%
3 Year Est. Return
+122.22%
5 Year Est. Return
+164.22%
10 Year Est. Return
–
AUM
$270M
AUM Growth
+$52.1M
(+24%)
Cap. Flow
+$22M
Cap. Flow
% of AUM
8.14%
Top 10 Holdings %
Top 10 Hldgs %
40.76%
Holding
941
New
464
Increased
200
Reduced
32
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$1.34M |
| 2 |
ExxonMobil
XOM
|
+$1.31M |
| 3 |
Chevron
CVX
|
+$1.25M |
| 4 |
Eli Lilly
LLY
|
+$685K |
| 5 |
JPMorgan Chase
JPM
|
+$684K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.18M |
| 2 |
NVIDIA
NVDA
|
+$618K |
| 3 |
Broadcom
AVGO
|
+$138K |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$113K |
| 5 |
Apple
AAPL
|
+$105K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 44.15% |
| 2 | Healthcare | 9.98% |
| 3 | Consumer Staples | 7.57% |
| 4 | Financials | 6.32% |
| 5 | Industrials | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
VanEck Junior Gold Miners ETF
GDXJ
$7.06B
| $11.6K | ﹤0.01% |
300
| – | – |
|
527
Atkore
ATKR
$2.59B
| $11.6K | ﹤0.01% |
+61
| New | +$9.76K |
|
528
Performance Food Group
PFGC
$17.5B
| $11.6K | ﹤0.01% |
+155
| New | +$11.4K |
|
529
Nordson
NDSN
$16.5B
| $11.5K | ﹤0.01% |
+42
| New | +$10.9K |
|
530
British American Tobacco
BTI
$132B
| $11.5K | ﹤0.01% |
+378
| New | +$11.4K |
|
531
Invesco S&P 500 Equal Weight Consumer Discretionary ETF
RSPD
$299M
| $11.5K | ﹤0.01% |
225
| – | – |
|
532
FirstEnergy
FE
$28.9B
| $11.4K | ﹤0.01% |
+295
| New | +$11K |
|
533
Piper Sandler
PIPR
$5.14B
| $11.3K | ﹤0.01% |
+228
| New | +$10.4K |
|
534
Teradyne
TER
$54.8B
| $11.3K | ﹤0.01% |
+100
| New | +$10.4K |
|
535
Tandem Diabetes Care
TNDM
$1.17B
| $11.2K | ﹤0.01% |
315
+215
| +215% | +$5.76K |
|
536
International Flavors & Fragrances
IFF
$19.4B
| $11.1K | ﹤0.01% |
+128
| New | +$10.3K |
|
|
CCC
537
CCC Intelligent Solutions
CCC
$3.42B
| $11K | ﹤0.01% |
+917
| New | +$10.5K |
|
538
AstraZeneca
AZN
$263B
| $10.9K | ﹤0.01% |
+81
| New | +$10.7K |
|
539
Booking.com
BKNG
$138B
| $10.9K | ﹤0.01% |
+75
| New | +$10.7K |
|
540
iShares US Real Estate ETF
IYR
$4.59B
| $10.8K | ﹤0.01% |
120
| – | – |
|
541
AES
AES
$10.6B
| $10.8K | ﹤0.01% |
600
| – | – |
|
542
Federal Signal
FSS
$7.25B
| $10.7K | ﹤0.01% |
+126
| New | +$9.87K |
|
543
Aon
AON
$77.3B
| $10.7K | ﹤0.01% |
+32
| New | +$9.92K |
|
544
Altria Group
MO
$122B
| $10.7K | ﹤0.01% |
239
+91
| +61% | +$3.77K |
|
545
iShares Global Energy ETF
IXC
$2.71B
| $10.7K | ﹤0.01% |
248
| – | – |
|
546
Johnson Controls International
JCI
$87.5B
| $10.6K | ﹤0.01% |
+162
| New | +$9.44K |
|
547
Viatris
VTRS
$20.1B
| $10.6K | ﹤0.01% |
891
+880
| +8,000% | +$10.6K |
|
548
Integer Holdings
ITGR
$3.35B
| $10.6K | ﹤0.01% |
+91
| New | +$9.67K |
|
549
Teck Resources
TECK
$29.5B
| $10.5K | ﹤0.01% |
+230
| New | +$9.23K |
|
550
Bruker
BRKR
$9.2B
| $10.5K | ﹤0.01% |
+112
| New | +$9.01K |
|
Similar funds
SM
RHP
MSWM
RLIM
JCM
CA
NRC
MFC
Front Row Advisors's Q1 2024 Portfolio in Review
As of Q1 2024, Front Row Advisors held 941 positions worth $270M, up 24% from $218M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Front Row Advisors deployed $22M of net new capital in Q1 2024, opening 464 new positions and adding to 200 existing holdings. Its largest new stake was Vanguard Information Technology ETF: 8,008 shares worth $525K.
By sector, the portfolio is most concentrated in Technology at 44% of assets, down from 46% a quarter earlier, followed by Healthcare and Consumer Staples.
On the sell side, the largest reduction was Pfizer, an estimated $1.18M trimmed.
- Front Row Advisors's largest Q1 2024 buy was Vanguard Information Technology ETF: 8,008 shares worth $525K.
- Front Row Advisors added most to Berkshire Hathaway Class B in Q1 2024, an estimated $1.34M increase.
- Front Row Advisors's biggest Q1 2024 reduction was Pfizer, cutting an estimated $1.18M.
- Front Row Advisors fully exited Atlantica Sustainable Infrastructure plc Ordinary Shares in Q1 2024, selling an estimated $16.2K.
- Front Row Advisors's ten largest holdings make up 41% of its $270M portfolio in Q1 2024.
- Front Row Advisors opened 464 new positions and closed 8 in Q1 2024.
- Front Row Advisors's portfolio value rose 24% quarter-over-quarter to $270M.
Based on Front Row Advisors's 13F filing for Q1 2024, filed 14 May 2024.